# FDA 483 - Vitalant - February 18, 2022

Source: https://www.keypedia.com/records/483/vitalant/28674cd7-f309-49cf-ba8d-041d5564eee1

> FDA 483 for Vitalant on February 18, 2022. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Vitalant
- Inspection Date: 2022-02-18
- Product Type: biologics
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: Vitalant, a blood bank in Brisbane, CA, was inspected by the FDA from February 9-18, 2022. The inspection revealed one significant observation concerning the firm's failure to adhere to manufacturer instructions for a component collection system. This lapse resulted in incorrect expiration dating for irradiated red blood cell units.

## Related Documents

- [483 - 2025-06-12](https://www.keypedia.com/records/483/vitalant/44d7f695-2211-4988-a89f-bf7335133ed0)

## Related Officers

- [Shelley H. Beausoleil](https://www.keypedia.com/people/shelley-h-beausoleil/1212116b-e24d-4bbc-a27a-5c16334d573e)
- [Richard L. Bartlett](https://www.keypedia.com/people/richard-l-bartlett/602337b9-ac77-41bb-a254-71a9d345335b)

Company: https://www.keypedia.com/companies/vitalant/f184cb37-ef39-4557-b97b-71b2baae5fef

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b